Smart nanomaterials for biomedics

Journal of Biomedical Nanotechnology

Volumn 10, Issue 10, 2014, Pages 3162-3188

  Choi, Soonmo ^a   Tripathi, Anuj ^b   Singh, Deepti ^a  

^a Yeungnam University   (South Korea)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Biomedics; Dendrimers; Gene delivery; Intracellular trafficking; Magnetic nanoparticles; Nanomaterials; Photodynamic therapy

Indexed keywords

CELL CULTURE; DENDRIMERS; DIAGNOSIS; FUNCTIONAL GROUPS; GENE THERAPY; GENE TRANSFER; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; NATURAL POLYMERS; PHOTODYNAMIC THERAPY; REPAIR;

BIOMEDICS; CELL CULTURE SCAFFOLDS; CIRCULATING TUMOR CELLS; GENE DELIVERY; INTRACELLULAR TRAFFICKING; MAGNETIC NANO-PARTICLES; PHYSICOCHEMICAL PROPERTY; SURROUNDING ENVIRONMENT;

SCAFFOLDS (BIOLOGY);

DENDRIMER; DNA; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCAPSULE; NANOMATERIAL; POLYMER; TISSUE SCAFFOLD;

APOPTOSIS; BIOMEDICINE; BIOSENSOR; CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CIRCULATING TUMOR CELL; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; REVIEW; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REPAIR; ANIMAL; CHEMISTRY; GENE TRANSFER; GENETIC PROCEDURES; MEDICAL TECHNOLOGY; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; BIOMEDICAL TECHNOLOGY; BIOSENSING TECHNIQUES; GENE TRANSFER TECHNIQUES; HUMANS; NANOCAPSULES; NANOSTRUCTURES; TISSUE ENGINEERING;

EID: 84905655290     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1933     Document Type: Review

References (285)

1. S. C. Curall, E. B. King, N. Lane, J. Madera, and S. Turner, What drives public acceptance of nanotechnology? Nat. Nanotechnol. 1, 153 (2006).
2. S. C. Curall, E. B. King, N. Lane, J. Madera, and S. Turner, How fast should nanotechnology advance? Nat. Nanotechnol. 2, 327 (2007).
3. H. S. Nalwa (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles, CA (2004/2011), Vols. 1-25.
4. H. S. Nalwa (ed.), Handbook of Nanostructured Materials and Nanotechnology, Academic Press, San Diego, CA (2000), Vols. 1-5.
5. A. Kumar, X. Zhang, and X. J. Liang, Gold nanoparticles: Emerging paradigm for targeted drug delivery system. Biotechnol. Adv. 31, 593 (2013).
6. D. M. Webster, P. Sundaram, and M. E. Byrne, Injectable nanomaterials for durg delivery: Carriers, targeting moieties, and therapeutics. Eur. J. Pharm. Biopharm. 84, 1 (2013).
7. S. Nazir, T. Hussain, A. Ayub, U. Rashid, and A. J. Macrobert, Nanomaterials in combating cancer: Therapeutic applications and developments. Nanomedicine 10, 19 (2014).
8. R. Farr, D. S. Choi, and S. W. Lee, Phage-based nanomaterials for biomedical applications. Acta Biomater. 13, S1742 (2013).
9. M. Malmsten, Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA. Curr. Opin. Colloid Interface Sci. 18, 468 (2013).
10. M. S. Shim and Y. J. Kwon, Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv. Drug Deliv. Rev. 64, 1046 (2012).
11. R. Lehner, X. Wang, S. Marsch, and P. Hunziker, Intelligent nanomaterials for medicine: Carrier platforms and targeting strategies in the context of clinical application. Nanomedicine 9, 742 (2013).
12. R. Fanciullino, J. Ciccolini, and G. Milano, Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs. Crit. Rev. Oncol. Hemat. 88, 504 (2013).
13. E. S. Khafagy, M. Morishita, Y. Onuki, and K. Takayama, Current challenges in non-invasive insulin delivery systems: A comparative review Adv. Drug Deliv. Rev. 59, 1521 (2007).
14. A. Maroni, L. Zema, M. D. D. Curto, A. Foppoli, and A. Gazzaniga, Oral colon delivery of insulin with the aid of functional adjuvants. Adv. Drug Deliv. Rev. 64, 540 (2012).
15. N. S. Santos-Magalhaes and V. C. Furtado-Mosqueira, Nanotechnology applied to the treatment of malaria. Adv. Drug Deliv. Rev. 62, 560 (2010).
16. M. B. Bally, P. Harvie, F. M. P-Wong, S. Kong, E. K. Wasan, and D. L. Reimer, Biological barriers to cellular delivery of lipid-based DNA carriers. Adv. Drug Deliv. Rev. 38, 291 (1999).
17. A. Mihranyan, N. Ferraz, and M. Stomme, Current status and future prospects of nanotehcnology in cosmetics. Prog. Mater. Sci. 57, 875 (2012).
18. T. M. Allen and P. R. Cullis, Liposomal drug delivery systems: From concept to clinical applications. Adv. Drug Deliv. Rev. 65, 36 (2013).
19. S. Ibsen, M. Benchimol, D. Sjmberg, C. Schutt, J. Steiner, and S. Esener, A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J. Control. Release 155, 358 (2011).
20. J. A. Hubbell and A. Chikoti, Nanomaterials for drug delivery Science 337, 303 (2012).
21. M. R. Prausnitz and R. Langer, Transdermal drug delivery. Nat. Biotech. 26, 1261 (2008).
22. S. N. Andrews, E. Jeong, and M. R. Prausnitz, Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm. Res. 30, 1099 (2013).
23. L. T. Fox, M. Gerber, J. Du Plessis, and J. H. Hamman, Transdermal drug delivery enhancement by compounds of natural origin. Molecules 16, 10507 (2011).
24. D. K. Kirui, I. Khalidov, Y. Wang, and C. A. Batt, Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging. Nanomedicine 9, 702 (2013).
25. G. M. Bernal, M. J. Lariviere, N. Mansour, P. Pytel, K. E. Cahill, D. J. Voce, S. Kang, R. Spretz, U. Welp, S. E. Noriega, L. Nunez, G. Larsen, R. R. Weichselbaum, and B. Yamini, Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 10, 149 (2014).
26. P. Juzenas, W. Chen, Y. P. Sun, M. A. Coelho, R. Generalov, N. Generalova, and I. Christensen, Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev. 60, 1600 (2008).
27. A. Mesbahi, A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. Rep. Prac. Oncol. Radiother. 15, 176 (2010).
28. U. Cheng, R. A. Morshed, B. Auffinger, A. L. Tobias, and M. S. Lesnjak, Multifunctional nanoparticles for brain tumor imaging and therapy. Adv. Drug Deliv. Rev. 409, 201 (2013).
29. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier, Nanocapsule technology: A review. Crit. Rev. Ther. Drug Carrier Syst 19, 99 (2002).
30. M. Delcea, H. Mohwald, and A. G. Skitach, Stimuli-responsive LBL capsules and nanoshells for drug delivery. Adv. Drug Deliv. Rev. 63, 730 (2011).
31. M. Delgado, A. Lazaro, J. Mazo, and B. Zalba, Review on phase change material emulsions and microencapsulated phase change material slurres: Materials, heat transfer studies and applications. Renew. Sust. Energ. Rev. 16, 253 (2012).
32. L. Mei, Z. Zhang, L. Zhao, L. Huang, X. L. Yang, J. Tang, and S. S. Feng, Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv. Drug Deliv. Rev. 65, 880 (2013).
33. P. Jin, S. J. Dalgarno, and J. L. Atwood, Mixed metal-organic nanocapsules. Coord. Chem. Rev. 254, 1760 (2010).
34. K. Ariga, Y. M. Lvov, K. Kawakami, Q. Ji, and J. P. Hill, Layer-by-layer self-assembled shells for drug delivery. Adv. Drug Deliv. Rev. 63, 762 (2011).
35. C. E. Mora-Huertas, H. Fessi, and A. Elaissari, Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 385, 113 (2010).
36. M. Morales-Cruz, G. M. Floes-Fernandez, M. Morales-Cruz, E. A. Orellano, J. A. Rodriguesz-Martinez, M. Ruiz, and K. Griebenow, Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres. Results Pharma Sci. 2, 79 (2012).
37. C. Moorthi and K. Kathiresan, Fabrication of highly stable sonication assisted curcumin nanocrystals by nanoprecipitation method. Drug Inven. Today 5, 66 (2013).
38. H. Fessi, F. Puisieux, J. Ph, Devissaguet, N. Ammoury, and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55, R1 (1989).
39. S. Khoee and M. Yaghoobian, An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur. J. Med. Chem. 44, 2392 (2009).
40. D. N. deAssis, V. C. Mosqueira, J. M. Vilela, M. S. Andrade, and V. N. Cardoso, Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99m Technetium-fluconazole nanocapsules. Int. J. Pharm. 349, 152 (2008).
41. T. Sugimoto, Preparation of monodispersed colloidal particles. Adv. Collid Interfac. 28, 65 (1987).
42. F. Lince, D. L. Marchisio, and A. A. Barresi, Strategies to control the particle size distribution of poly-ε-caprolactone nanoparticles for pharmaceutical applications. J. Colloid Interface Sci. 322, 505 (2008).
43. A. Ganem-Quintanar, D. Quintanar-Guerrero, F. Falson-Rieg, and P. Buri, Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int. J. Pharm. 173, 203 (1998).
44. D. Quintanar-Guerrero, D. Tamayo-Esquivel, A. Ganem-Quintanar, E. Allemann, and E. Doelker, Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur. J. Pharm. Sci. 26, 211 (2005).
45. M. Hassou, Modelisation et simulation de la formation des nanocapsules polymeriques par la methode d'emulsion-diffusion., PhD thesis, University Claoude Bernard-Lyon. (web link; http://hal.archives-ouvertes.fr/tel-00264755/) (2010).
46. D. Moinard-Chécot, Y. Chevalier, S. Briancon, L. Beney, and H, Fessi, Mechanism of nanocapsules formation by the emulsion-diffusion process. J. Colloid Interface Sci. 317, 458 (2008).
47. A. G. Coombes, M. K. Yeh, E. C. Lavelle, and S. S. Davis, The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. J. Control Release 52, 311 (1998).
48. S. Marquette, C. Peerboom, A. Yates, L. Denis, J. Goole, and K. Amighi, Encapsulation of immunoglobulin G by solid-in-oil-in-water: Effect of process parameters on microsphere properties. Eur. J. Pharm. Biopharm. S00339-1 (2013), doi: 10.1016/j.ejpb.2013.10.013.
49. S. Khoee and M. Yaghoobian, An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur. J. Med. Chem. 44, 2392 (2009).
50. U. Bilati, E. Allemann, and E. Doelker, Poly(D,L-lactide-coglycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency. J. Microencapsul. 22, 205 (2005).
51. U. Shinde and M. Nagarsenker, Microencapsulation of eugenol by gelatin-sodium alginate complex coacervation. Indian. J. Pharm. Sci. 73, 311 (2011).
52. U. A. Shinde and M. S. Nagarsenker, Characterization of gelatin-sodium algineate complex coacervation system. Indian. J. Pharm. Sci. 71, 313 (2009).
53. M. Wang, Y. Fan, Y. Han, Z, Nie, and Y. Wang, Coacervation of cationic Gemini surfactant with N-benzoylglutamic acid in aqueous solution. Langmuir. 29, 14839 (2013).
54. P. Lertsutthiwong, K. Noomun, N. Jongaroonngamsang, P. Rojsitthisak, and U. Nimmannit, Prepation of alginate nanocapsules containing turmeric oil. Carbohyd. Polym. 74, 209 (2008).
55. H. J. Krause and P. Rohdewald, Preparation of gelatin nanocapsules and their pharmaceutical characterization. Pharm. Res. 2, 239 (1985).
56. S. Lutter, J. Koetz, B. Tiersch, A. Boschetti-de-Fierro, and V. Abetz, Formation of gold nanoparticles in triblock terpolymer-modified inverse microemulsions. Colloid Surface A 329, 169 (2008).
57. A. O. Elzoghby, W. S. EI-Fotoh, and N. A. Elhindy, Casein-based formulations as promising controlled release drug delivery systems. J. Control Release 153, 206 (2011).
58. Y. Lu, J. Yuan, F. Polzer, M. Drechsler, and J. Preussner, In situ growth of catalytic active Au-Pt bimetallic nanorods in thermoresponsive core-shell microgels. ACS Nano 4, 7078 (2010).
59. W. Wu, T. Zhou, J. Shen, and S. Zhou, Optical detection of glucose by CdS quantum dots immobilized in smart microgels. Chem. Commun. 29, 4390 (2009).
60. A. Femandez-Barbero, I. J. Suarez, B. Sierra-Martin, A. Femandez-Nieves, F. J. de Las Nieves, M. Marquez, J. Rubio-Retama, and E. Lopez-Cabarcos, Gels and microgels for nanotechnological applications. Adv. Colloid Interface Sci. 147-148, 88 (2009).
61. J. K. Oh, R. Drumright, D. J. Siegwart, and K. Matyjaszewski, The development of microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 33, 448 (2008).
62. H. Bysell, R. Mansson, P. Hansson, and M. Malmsten, Microgels and microcapsules in peptide and protein drug delivery. Adv. Drug Deliv. Rev. 63, 1172 (2011).
63. D. Klinger and K. Landfester, Stimuli-responsive microgels for the loading and release of functional compounds: Fundamental concepts and applications. Polymer 53, 5209 (2012).
64. J. K. Oh, D. I. Lee, and J. M. Park, Biopolymer-based microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 34, 1261 (2009).
65. B. R. Saunders, N. Laajam, E. Daly, S. Teow, X. Hu, and R. Stepto, Microgels: From responsive polymer colloids to biomaterials. Adv. Colloid Interface Sci. 147-148, 251 (2009).
66. J. E. Wong and W. Richtering, Layer-by-layer assembly on stimuli-responsive microgels. Curr. Opin. Colloid Interface Sci. 13, 403 (2008).
67. H. Staudinger, W. Heuer, E. Husemann, and I. J. Rabinovitch, The insoluble polystyrene. Trans. Faraday Soc. 32, 323 (1936).
68. W. O. Baker, Microgel, a new macromolecule. Ind. Eng. Chem. 41, 511 (1949).
69. M. Ratanajanchai, D. Tanwilai, and P. Sunintaboon, Visible light-induced surfactant-free emulsion polymerization using camphorquinone/tertiary amine as the initiating system for the synthesis of amine-functionalized colloidal nanoparticles. J. Colloid Interface Sci. 409, 25 (2013).
70. P. J. Roth, F. D. Jochum, R. Zentel, and P. Theato, Synthesis of hetero-telechelic alpha, omega bio-functionalized polymers. Biomolecules 11, 238 (2010).
71. B. T. Cheesman, A. J. Neilson, J. D. Willott, G. B. Webber, S. Edmondson, and E. J. Wanless, Effect of colloidal substrate curvature on pH-responsive polyelectrolyte brush growth. Langmuir 29, 6131 (2013).
72. S. E. A. Gratton, P. D. Pohlhaus, J. Lee, J. Guo, M. J. Cho, and J. M. DeSimone, Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT nanoparticles. J. Control Release 121, 10 (2007).
73. S. S. Williams, S. Retterer, R. Lopez, R. Ruiz, E. T. Samulski, and J. M. DeSimone, High-resolution PEPE-based molding techniques for nanofabrication of high-pattern density, sub-20 nm features: A fundamental materials approach. Nano Lett. 10, 1421 (2010).
74. V. A. Schulte, Y. Hu, M. Diez, D. Bunger, M. Moller, and M. C. Lensen, A hydrophobic perfluoropolyether elastomer as a patternable biomaterial for cell culture and tissue engineering. Biomaterials 31, 8538 (2010).
75. R. G. Hobbs, R. A. Farrell, C. T. Bolger, R. A. Kelly, M. A. Morris, N. Retkov, and J. D. Holmes, Selective sidewall wetting of polymer blocks in hydrogen silsesquioxane directed self assembly of PS-b-PDMS. ACS Appl. Mater. Interfaces 4, 4637 (2012).
76. T. G. Van Thiene, J. Demeester, and S. C. De Smedt, Screening poly(ethyleneglycol) micro- and nanogels for drug delivery purposes. Int. J. Pharm. 351, 174 (2008).
77. T. Eckert and E. Bartsch, The effect of free polymer on the interactions and the glass transition dynamics of microgel colloids. Faraday Discuss. 123, 75 (2003).
78. S. Pipemo, L. A. Gheber, P. Canton, A. Pich, G. Dvorakova, and A. Biffis, Microgel electrospinning: A novel tool for the fabrication of nanocomposite fibers. Polymer 50, 6193 (2009).
79. R. Ladj, A. Bitar, M. M. Eissa, H. Fessi, Y. Mugnier, R. Le Dantec, and A. Elaissari, Polymer encapsulation of inorganic nanoparticles for biomedical applications. Int. J. Pharm. 458, 230 (2013).
80. Y. Lu and M. Ballauff, Thermosensitive core-shell microgels: From colloidal model systems to nanoreactors. Prog. Polym. Sci. 36, 767 (2011).
81. Y. Y. Liu, X. Y. Liu, J. M. Yang, D. L. Lin, X. Chen, and L. S. Zha, Investigation of Ag nanoparticles loading temperature responsive hybrid microgels and their temperature controlled catalytic activity. Colloid Surface A 393, 105 (2012).
82. J. Rubio-Retama, N. E. Zafeiropoulos, C. Serafinelli, R. Rojas-Reyna, B. Voit, E. L. Cabarcos, and M. Stamm, Synthesis and characterization of thermosensitive PNIPAM microgels covered with superparamagnetic gamma-Fe 2O3 nanoparticles. Langmuir 23, 10280 (2007).
83. Y. Zhang, Y. Fang, H. Xia, Y. Xie, R. Wang, and X. Li, Preparation of AgCl-polyacrylamide composite microspheres via combination of a polymer microgel template method and a reverse micelle technique. J. Colloid Interface Sci. 300, 210 (2006).
84. A. K. lyer, A. Singh, S. Ganta, and M. M. Arniji, Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Deliv. Rev. 65, 1784 (2013).
85. M. Boustta, P. E. Colombo, S. Lenglet, S. Pouhol, and M. Vert, Versatile UCST-based thermoresponsive hydrogels for loco-regional sustained drug delivery. J. Control Release 174, 1 (2014).
86. A. Alexander, Ajazuddin, J. Khan, S. Saraf, and S. Saraf, Poly(ethylebe glycol)-poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications. J. Control Release 172, 715 (2013).
87. J. Sarobe, I. Miraballes, J. Antonio, J. Forcada, and R. H. I. Alva, Nephelometric assay of immunoglobulin G Chemically bound to chloromethyl styrene beads. Polym. Advan. Technol. 7, 749 (1996).
88. M. Hasanzadeh, N. Shadjou, M. Eskandani, J. Soleymani, F. Jafari, and M. de la Guardia, Dendrimer-encapsulated and cored metal nanoparticles for electrochemical nanobiosensing. TrAC Trend Anal. Chem. 53, 137 (2014).
89. A. M. Caminade, R. Laurent, M. Zablocka, and J. P. Majoral, Organophosphorus chemistry for the synthesis of dendrimers. Molecules 17, 13605 (2012).
90. S. Mignani, S. E. Kazzouli, M. Bousmina, and J. P. Majoral, Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry. Prog. Polym. Sci. 38, 993 (2013).
91. H. Arima, K. Motoyama, and T. Higashi, Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors. Adv. Drug Deliv. Rev. 65, 1204 (2013).
92. S. Mignani, S. E. Kazzouli, M. Bousmina, and J. P. Majoral, Expand classical drug administration ways by emerging routes using dendrmer drug delivery systems: A concise overview. Adv. Drug Deliv. Rev. 65, 1316 (2013).
93. S. H. Hwang, C. N. Moorefield, P. Wang, K. U. Jeong, S. Z. Cheng, K. K. Kotta, and G. R. Newkome, Construction of CdS quantum dots via a regioselective dendritic functionalized cellulose template. Chem. Commun. 33, 3495 (2006).
94. Q. R. Huang, P. L. Dubin, J. Lal, C. N. Moorefield, and G. R. Newkome, Small-angle neutron scattering studies of charged carboxyl-teminated dendrimers in solutions. Langmuir 21, 2737 (2005).
95. D. A. Tomalia, Interview: An architectural journey: From tress, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. Nanomedicine-UK 7, 953 (2012).
96. A. R. Menjoge, R. M. Kannan, and D. A. Tomalia, Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discov. Today 15, 171 (2010).
97. D. A. Tomalia, L. A. Reyna, and S. Svenson, Dendrimers as multipurpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 35, 61 (2007).
98. D. A. Tomalia, B. Huang, D. R. Swanson, H. M. Brothers II, and J. W. Klimash, Structure control within poly(amidoamine) dendrimers: Size, shape and region-chemical mimicry of globular proteins. Tetrahedron 59, 3799 (2003).
99. D. K. Smith, A. R. Hirst, C. S. Love, J. G. Hardy, S. V. Brignell, and B. Huang, Self-assembly using denderitic building blocks-towards controllable nanomaterials. Prog. Polym. Sci. 30, 220 (2005).
100. L. Zhang, L. Wang, Y. Hu, Z. Liu, Y. Tian, X. Wu, Y. Zhao, H. Tang, C. Chen, and Y. Wang, Selective metabolic effects of gold nanorods on normal and cancer cells and their application in anticancer drug screening. Biomaterials 34, 7117 (2013).
101. F. S. Mehrabadi, W. Fischer, and R. Haag, Dendritic and lipid-based carriers for gene/siRNA delivery (a review). Curr. Opin. Solid St. M 16, 310 (2012).
102. M. Nasr, M. Najlah, A. D'Emanuele, and A. Elhissi, PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization. Int. J. Pharm. 461, 242 (2014).
103. M. Ciolkowski, M. Rozanek, M. Bryszewska, and B. Klajnert, The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. BBA-Proteins Proteomics 1834, 1982 (2013).
104. S. Sadekar and H. Ghandehari, Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery. Adv. Drug Deliv. Rev. 64, 571 (2012).
105. Y. Wang and S. M. Grayson, Approaches for the preparation of nonlinear amphiphilic polymers and their applications to drug delivery. Adv. Drug Deliver. Rev. 64, 852 (2012).
106. D. Shcharbin, E. Pedziwiatr, J. Blasiak, and M. Bryszewska, How to study dendriplexes II: Transfection and cytotoxicity. J. Control Release 141, 110 (2010).
107. O. P. Perumal, R. Inapagolla, S. Kannan, and R. M. Kanna, The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 29, 3469 (2008).
108. H. C. Tsai and T. Imae, Fabrication of dendrimers toward biological application. Prog. Mol. Biol. Transl. 104, 101 (2011).
109. D. M. Domanski, B. Klajnert, and M. Bryszewska, Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry 63, 189 (2004).
110. H. L. Amand, C. L. Bostrom, P. Lincoln, B. Norden, and E. K. Esbjorner, Binding of cell-penetrating penetratin peptides to plasma membrane vesicles correlates directly with cellular uptake. BBA-Biomembranes 1808, 1860 (2011).
111. J. D. Eichman, A. U. Bielinska, J. F. Kukowska-Latallo, B. W. Donovan, and J. R. Baker, Bioapplications of PAMAM dendrimers, edited by J. M. M. Frechet and D. A. Tomalia, John Wiley & Sons, New York (2001), pp. 441-461.
112. S. Hong, P. R. Leroueil, I. Majoros, B. G. Orr, J. R. Baker, and M. M. Banaszak Holl, The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14, 107 (2007).
113. S. Svenson and D. A. Tomalia, Dendrimers in biomedical applications-reflections on the field. Adv. Drug Deliv. Rev. 57, 2106 (2012).
114. T. W. Cha, A. Guo, and X. Y. Zhu, Formation of supported phospholipid bilayers on molecular surfaces: Role of surface charge Density and electrostatic interaction. Biophys. J. 90, 1270 (2006).
115. A. P. Pandey, F. Haque, J. C. Rochet, and J. S. Hovis, Clustering of α-synuclein on supported lipid bilayers: Role of anionic lipid, protein, and divalent ion concentration. Biophys. J. 96, 540 (2009).
116. L. V. Schagina, P. A. Gurnev, J. Y. Takemoto, and V. V. Malev, Effective gating charge of ion channels induced by toxin syringomycin E in lipid bilayers. Bioelectrochemistry 60, 21 (2003).
117. L. Jia, J. P. Xu, H. Wang, and J. Ji, Polyamidoamine dendrimers surface-engineered with biomimetic phosphorylcholine as potential drug delivery carriers. Colloid. Surface. B 84, 49 (2011).
118. O. O. Markov, N. L. Mironova, M. A. Maslov, I. A. Petukhov, N. G. Morozova, V. V. Vlassov, and M. A. Zenkova, Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets. J. Control Release 160, 200 (2012).
119. N. Wang, Y. Guan, L. Yang, L. Jia, X. Wei, H. Liu, and C. Guo, Magnetic nanoparticles (MNPs) covalently coated by PET-PPOPET block copolymer for drug delivery. J. Colloid Interface Sci. 395, 50 (2013).
120. O. Veiseh, J. W. Gunn, and M. Zhang, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62, 284 (2010).
121. T. K. Jain, S. P. Foy, B. Erokwu, S. Dimitrijevic, C. A. Flask, and V. Labhasetwar, Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 30, 6748 (2009).
122. S. Conroy, S. H. Jerry, and M. Zhang, Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 60, 1252 (2008).
123. K. Murase, H. Takata, Y. Takeuchi, and S. Saito, Control of the temperature rise in magnetic hyperthermia with use of an external static magnetic field. Phys. Med. 29, 624 (2013).
124. Y. Xu and E. Wang, Electrochemical biosensors based on magnetic micro/nano particles. Electrochim. Acta 84, 62 (2012).
125. M. Glinka, S. Gawron, A. Sieron, K. Pawlowska-Goral, G. Cieslar, and K. Sieron-Stoltny, Test chambers for cell culture in static magnetic field. J. Magn. Magn. Mater. 331, 208 (2013).
126. C. F. Adams, M. R. Pickard, and D. M. Chari, Magnetic nanoparticle mediated transfection of neural stem cell suspension cultures is enhanced by applied oscillating magnetic fields. Nanomedicine 9, 737 (2013).
127. V. Ortner, C. Kaspar, C. Halter, L. Tolner, O. Mykhaylyk, J. Walzer, W. H. Gunzburg, J. A. Dangerfield, C. Hohenadl, and T. Czemy, Magnetic field-controlled gene expression in encapsulated cells. J. Control Release 158, 424 (2012).
128. J. H. Shin, C. H. Yoo, J. H. Lee, and M. S. Cha, Cell response induced by internalized bacterial magnetic nanoparticles under an external static magnetic field. Biomaterials 33, 5650 (2012).
129. A. R. Qian, X. Gao, W. Zhang, J. B. Li, Y. Wang, S. M. Di, L. F. Hu, and P. Shang, Large gradient high magnetic fields affect osteoblast ultrastructure and function by disrupting collagen I or fibronectin/αβ1 integrin. Plos One 8, e51036 (2013).
130. R. Sensenig. Y. Sapir, C. MacDonal, S. Cohen, and B. Polyak, Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo. Nanomedicine-UK 7, 1425 (2012).
131. J. H. Lee, M. V. Yigit, D. Mazumdar, and Y. Lu, Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv. Drug Deliv. Rev. 62, 592 (2010).
132. W. Putzbach and N. J. Ronkainen, Immobilization techniques in the fabrication of nanomaterial-based electrochemical biosensors: A review. Sensors-Basel 13, 4811 (2013).
133. X. Q. Zhang, X. Xu, N. Bertrand, E. Pridgen, A. Swami, and O. C. Farokhzad, Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv. Drug Deliv. Rev. 64, 1363 (2012).
134. B. C. Lee, T. K. Chu, K. A. Dill, and R. N. Zuckermann, Biomimetic nanostructures: Creating a high-affinity zinc-binding site in a folded nonbiological polymer. J. Am. Chem. Soc. 130, 8847 (2008).
135. T. Chung, S. Y. Lee, E. Y. Song, H. G. Chun, and B. H. Lee, Plasmonic nanostructures for nano-scale bio-sensing. Sensors(Basel) 11, 10907 (2011).
136. J. I. Reyes De Corcuera and R. P. Cavalieri, Biosensors, Encyclopedia of Agricultural, Food, and Biological Engineering. Marcel Dekker, New York (2003), pp. 119-123.
137. D. Stratis-Cullum and J. Sumnet, Bio-Inspired Innovation and National Security, edited by R. E. Armstrong, M. D. Drapeau, C. A. Loeb, and J. J. Valdes, NDU Press, Washington, D.C. (2010), pp. 77-103.
138. A. Sadana (ed.), Biosensors: Kinetics of Binding and Dissociation Using Fractals, Elsevier, Amsterdam (2003).
139. G. K. Knopf and A. S. Bassi, (eds.), Smart Biosensor Technology, CRC Press, Boca Racton (2007).
140. G. U. Flechsig, J. Peter, K. Voss, and P. Grundler, Electrochemical DNA hybridization detection using the fluorescence quenching label dabcyl. Electrochem. Commun. 7, 1059 (2005).
141. G. Liang, T. Li, X. Li, and X. Liu, Electrochemical detection of the amino-substituted naphthalene compounds basedd on intercalative interaction with hairpin DNA by electrochemical impedance spectroscopy. Biosens. Bioelectron. 48, 238 (2013).
142. S. Wang, T. Yin, S. Zeng, H. Che, F. Yang, X. Chen, G. Shen, and Z. Wu, A piezoelectric immunosensor using hybrid self-assembled monolayers for detection of Schistosoma japonicum. PLoS One 7, e30779 (2012).
143. X. Jiang, S. Zhang, J. Johnson, and G. Salazar, High-temperature piezoelectric sensing. Sensors(Basel) 14, 144 (2013).
144. E. Wijaya, C. Lenaerts, S. Maricot, J. Hastanin, S. Habraken, J. P. Vilcot, R. Boukherroub, and S. Szunerits, Surface plasmon resonance-based biosensors: From the development of different SPR structures to novel surface functionalization strategies. Curr. Opin. Solid St. M 15, 208 (2011).
145. Y. Xu, H. Lee, Y. Hu, J. Huang, S. Kim, and M. Yum, Detection and identification of breast cancer volatile organic compounds biomarkers using highly-sensitive single nanowire array on a chip. J. Biomed. Nanotechnol. 9, 1164 (2013).
146. C. Jianrong, M. Yuqing, H. Nongyue, W. Xiaohua, and L. Sijiao, Nanotechnology and biosensors. Biotechnol. Adv. 22, 505 (2004).
147. A. Bonanni and M. del Valle, Use of nanomaterials for impedimetric DNS sensors: A review. Anal. Chim. Acta 678, 7 (2010).
148. Z. Wang, A. V. Bussche, P. K. Kabadi, A. B. Kane, and R. H. Hurt, Biological and environmnetal transformations of copperbased nanomaterials. ACS Nano 7, 8715 (2013).
149. K. Zhang and S. Wang, Thermal and electronic transport of semiconducting nanoparticle-functionalized carbon nanotubes. Carbon 69, 46 (2014).
150. M. Larguinho and P. V. Baptista, Gold and silver nanoparticles for clinical diagnostics-From genomics to proteomics. J. Proteomics 75, 2811 (2012).
151. Y. C. Chuang, J. C. Li, S. H. Chen, T. Y. Liu, C. H. Kuo, W. T. Huang, and C. S. Lin, An optical biosensing platform for proteinase activity using gold nanoparticles. Biomateirals 31, 6087 (2010).
152. W. S. Hwang, P. L. Truong, and S. J. Sim, Size-dependent plasmonic responses of single gold nanoparticles for analysis of biorecognition. Anal. Biochem. 421, 213 (2012).
153. C. X. Zhang, Y. Zhang, X. Wang, Z. M. Tang, and Z. H. Lu, Hyper-rayleigh scattering of protein-modified gold nanoparticles. Anal. Biochem. 320, 136 (2003).
154. M. Chen, H. H. Cai, F. Yang, D. Lin, P. H. Yang, and J. Cai, Highly sensitive detection of chromium (III) ions by resonance Rayleigh scattering enhanced by gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc. 118, 776 (2014).
155. C. T. Nguyen, J. T. Nguyen, S. Rutledge, J. Zhang, C. Wang, and G. C. Walker, Detection of chronic lymphocytic leukemia cell surface markers using surface enhanced Raman scattering gold nanoparticles. Cancer Lett. 292, 91 (2010).
156. D. Danila, E. Johnson, and P. Kee, CT imaging of myocardial scars with collagen-targeting gold nanoparticles. Nanomedicine 9, 1067 (2013).
157. L. Vigderman and E. R. Zubarev, Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Adv. Drug Deliv. Rev. 65, 663 (2013).
158. M. Wang and M. Thanou, Targeting nanoparticles to cancer. Pharmacol. Res. 62, 90 (2010).
159. Y. M. Shirshow, B. A. Snopok, A. V. Samoylov, A. P. Kiyanovskij, E. F. Venger, A. V. Nabok, and A. K. Ray, Analysis of the response of planar polarization interferometer to molecular layer formation: Fibrinogen adsorption on silicon nitride surface. Biosens. Bioelectron. 16, 381 (2001).
160. K. S. Krishna, Y. Li, S. Li, and C. S. S. R. Kumar, Lab-on-a-chip synthesis of inorganic nanomaterials and quantum dots for biomedical applications. Adv. Drug Deliv. Rev. 65, 1470 (2013).
161. S. Dembski, S. Rupp, C. Gellermann, M. Batentschuk, A. Osvet, and A. Winnacker, Luminescent silicate core-shell nanoparticles: Synthesis, functionalization, optical, and structural properties. J. Colloid Interface Sci. 358, 32 (2011).
162. L. Dong, Z. Yang, Y. Zhang, Y. Zhu, L. Wang, and L. Wang, Novel luminescent nanoparticles for DNA detection. Spectrochim. Acta A Mol. Biomol. Spectrosc. 75, 1530 (2006).
163. N. D. Hoa, V. V. Quang, D. J. Kim, and N. V. Hieu, General and scalable route to synthesize nanowire-structured semiconducting metal oxides for gas-sensor applications. J. Alloy. Compd. 549, 260 (2013).
164. T. E. Pylaev, E. K. Volkova, V. I. Kochubey, V. A. Bogatyrev, and N. G. Khoebtsov, DNA detection assay based on fluorescence quenching of rhodamine B by gold nanoparticles: The optical mechanisms. J. Quant. Spectrosc. Radiat. Transfer 131, 34 (2013).
165. J. Thavanathan, N. M. Huang, and K. L. Thong, Colorimetric detection of DNA hybridization based on a dual platform of gold nanoparticles and graphene oxide. Biosens. Bioelectron. 55, 91 (2014).
166. H. M. Huttanus, E. Graugnard, B. Yurke, W. B. Knowlton, W. Kuang, W. L. Hughes, and J. H. Lee, Enhanced DNA sensing via catalytic aggregation of gold nanoparticles. Biosens. Bioelectron. 50, 382 (2013).
167. E. Auyeung, T. Li, A. J. Senesi, A. L. Schmucker, B. C. Pals, M. O. de la Cruz, and C. A. Mirkin, DNA-mediated nanoparticle crystallization in to Wulff polyhedra. Nature 505, 73 (2014).
168. Q. Liu, Z. Pu, A. M. Asiri, A. O. Al-Youbi, and X. Sun, Polyopamine nanospheres: A biopolymer-based fluorescent sensing platform for DNA detection. Sensor. Actuat. B-Chem. 191, 567 (2014).
169. L. B. Sagle, L. K. Ruvuna, J. M. Binghan, C. Liu, P. S. Cremer, and R. P. Van Duyne, Single plasmonic nanoparticle tracking studies of solid supported bilayers with ganglioside lipids. J. Am. Chem. Soc. 134, 15832 (2012).
170. K. L. Wustholz, A. I. Henry, J. M. McMahon, R. G. Freeman, N. Valley, M. E. Piotti, M. J. Natan, G. C. Schatz, and R. P. Van Duyne, Structure-activity relationships in gold nanoparticle dimers and trimers for surface-enhanced Raman spectroscopy. J. Am. Chem. Soc. 132, 10903 (2010).
171. R. Elghanian, J. J. Storhoff, R. C. Storhoff, R. C. Mucic, R. L. Letsinger, and C. A. Mirkin, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277, 1078 (1997).
172. C. C. Huang, Y. F. Huang, Z. Cao, W. Tan, and H. T. Chang, Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal. Chem. 77, 5735 (2005).
173. X. Zhang, D. B. Reeves, I. M. Perreard, W. C. Kett, K. E. Griswold, B. Gimi, and J. B. Weaver, Molecular sensing with magnetic nanoparticles using magnetic spectroscopy of nanoparticle Brownian motion. Biosens. Bioelectron. 50, 441 (2013).
174. Z. Gao, M. Xu, L. Hou, G. Chen, and D. Tang, Magnetic bead-based reverse colorimetric immunoassay strategy for sensing biomolecules. Anal. Chem. 85, 6945 (2013).
175. L. Ding, C. Hao, Y. Xue, and H. Ju, A bio-inspired support of gold nanoparticles-chitosan nanocomposites gel for immobilization and electrochemical study of K562 leukemia cells. Biomacromolecules 8, 1341 (2007).
176. H. Deng, A. K. L. Teo, and Z. Gao, An interference-free glucose biosensor based on a novel low potential redox polymer mediator. Sensor. Actuat. B-Chem. 191, 522 (2014).
177. L. Sasso, S. Suei, L. Domigan, J. Healy, V. Nock, M. A. Williams, and J. A. Gerrard, Versatile multi-functionalization of protein nanofibrils for biosensor applications. Nanoscale 6, 1629 (2013).
178. M. Zhang, R. Yuan, Y. Chai, W. Li, H. Zhong, and C. Wang, Glucose biosensor based on titanium dioxide-multiwall carbon nanotubes-chitosan composite and functionalized gold nanoparticles. Bioprocess Biosyst. Eng. 34, 1143 (2011).
179. M. L. Ho, J. C. Wang, T. Y. Wang, C. Y. Lin, J. F. Zhu, Y. A. Chen, and T. C. Chen, The construction of glucose biosensor based on crystallin iridium(III)-containing coordination polymers with fiberoptic detection. Sensor. Actuat. B-Chem. 1990, 479 (2014).
180. A. J. Kilard and M. R. Smyth, Creatinine biosensors: Principles and designs. Trends Biotechnol. 18, 433 (2000).
181. S. Prakash, T. Chakrabarty, A. K. Singh, and V. K. Shahi, Polymer thin films embedded with metal nanoparticles for electrochemical biosensors applications. Biosens. Bioelectron. 41, 43 (2013).
182. S. C. Kazmlerczak, F. V. Lente, and E. D. Hodges, Diagnostic and prognostic utility of phospholipase: A activity in patients with acute pancreatitis: Comparison with amylase and lipase. Clin. Chem. 37, 356 (1991).
183. M. Meyerhoff and G. A. Rechnitz, An activated enzyme electrode for creatinine. Anal. chim. Acta 85, 277 (1976).
184. M. E. Meyerhoff and W. N. Opdycke, Ion-selective electrodes. Adv. Clin. Chem. 25, 1 (1986).
185. G. S. Cha and M. E. Meyerhoff, Potentiometric ion- and bioselective electrodes based on asymmetric cellulose acetate membranes. Talanta 36, 271 (1989).
186. C. R. Geauer and G. A. Rechnitz, Deaminating enzyme labels for potentiometric enzyme immunoassay. Anal. Biochem. 124, 338 (1982).
187. C. L. Di Paolantonia and G. A. Rechnitz, Stabilized bacteria-based potentiometric electrode for pyruvate. Anal. Chim. Acta 148, 1 (1983).
188. C. L. Di Paolantonia and G. A. Rechnitz, Induced bacterial electrode for the potentiometric measurement of tyrosine. Anal. chim. Acta 141, 1 (1982).
189. G. G. Guilbault and P. R. Coulet, Creatinine-selective enzyme electrodes. Anal. Chim. Acta 152, 223 (1983).
190. Y. T. Shih and H. J. Huang, A creatinine deinimase modified polyaniline electrode for creatinine analysis. Anal. Chim. Acta 392, 143 (1999).
191. B. Sujoy and A. Aparna, Potential clinical significance of urease enzyme. Eur. Sci. J. 9, 94 (2013).
192. R. Ilangovan, D. Daniel, A. Krastanov, C. Zachariah, and R. Elizabeth, Enzyme based biosensor for heavy metal ions determination. Biotechnol. Biotechnol. Eq.? 20, 184 (2006).
193. W. R. Heineman, Biosensors based on polymer networks formed by gamma irradiation crosslinking. Appl. Biochem. Biotechnol. 41, 87 (1993).
194. B. Csoka, B. Kovacs, and G. Nagy, Investigation of concentration profiles inside operating biocatalytic sensors with scanning electrochemical microscopy (SECM). Biosens. Bioelectron. 18, 141 (2003).
195. N. Vasylieva, B. Barnych, A. Meiller, C. Maucler, L. Pollegioni, J. S. Lin, D. Barbier, and S. Marinesco, Covalent enzyme immobilization by poly(ethylene glycol) digly-cidyl ether (PEGDE) for microelectrode biosensor preparation. Biosens. Bioelectron. 26, 3993 (2011).
196. A. Deep, U. Tiwari, P. Kumar, V. Mishra, S. C. Jain, N. Singh, P. Kapur, and L. M. Bharadwaj, Immobilization of enzyme on long period grating fibers for sensitiveglucose detection. Biosens. Bioelectron. 33, 190 (2012).
197. M. Tyagi, M. Tomar, and V. Cupta, NiO nanoparticle-based urea biosensor. Biosens. Bioelectron. 41, 110 (2013).
198. Z. P. Yang, S. H. Si, and C. J. Zhang, Study on the activity and stability of urease immo-bilized onto nanoporous alumina membranes. Micropor. Mesopor. Mat. 111, 359 (2008).
199. X. Chen, Z. P. Yang, and S. H. Si, Potentiometric urea biosensor based on immobiliza-tion of urease onto molecularly imprinted TiO2 film. J. Electroanal. Chem. 635, 1 (2009).
200. K. Murai and K. Kato, Development of cholesterol biosensor with high sensitivity using dual-enzyme immobilization into the mesoporous silica materials. Appl. Surf. Sci. 258, 1725 (2011).
201. Z. Gao, G. Xu, Y. R. Ying, M. S. Mohamed Arshad, and F. Xie, Electrically non-conductive, nanoparticulate membrane. U. S. Patent 7,563,588, October 25 (2004).
202. S. Soylemez, F. E. Kanik, S. Tarkuc, Y. A. Udum, and L. Toppare, A sepiolite modified conducting polymer based biosensor. Colloids Surf. B Biointerfaces 111, 549 (2013).
203. W. T. Li, Handbook of Biophotonics. edited by J. Popp, V. V. Tuchin, A. Chiou, and S. Heinemann, Wiley-VCH, Weinhein (2012), Vol. 2, pp. 321-336.
204. D. K. Chatterjee, L. S. Fong, and Y. Zhang, Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 60, 1627 (2008).
205. N. S. James, T. Y. Chen, T. P. Joshi, X. Zheng, L. N. Goswami, and R. K. Pandey, Comperative tumor imaging and PDT efficacy of HPPH conjugated in the mono- and Di-forms to various polymethine cyanine dyes: Part-2. Theranostics 3, 703 (2013).
206. S. Hatz, J. D. Lambert, and P. R. Ogilby, Measuring the lifetime of siglet oxygen in a single cell: Addressing the issue of cell viability. Photochem. Photobiol. Sci. 6, 1106 (2002).
207. E. Buytaert, M. Dewaele, P and P. Agostinis, Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta 1776, 86 (2007).
208. B. Chen, B. W. Pogue, P. J. Hoopse, and T. Hasan, Vascular and cellular targeting for photodynamic therapy. Crit. Rev. Eukaryot. Expr. 16, 279 (2006).
209. D. E. Dolmans, D. Fukumura, and R. K. Jain. Photodynamic therapy of cancer. Nat. Rev. Cancer 3, 380 (2003).
210. D. Bechet, P. Couleaud, C. Frochot, M. L. Viriot, F. Guillemin, and M. Barberi-Heyob, Nanoparticles as vehicle for delivery of photodynamic therapy agents. Trends Biotechnol. 26, 612 (2008).
211. G. Jori, Tumor photosensitizers: Approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B 36, 87 (1996).
212. C. F. Nostrum, Polymeric micellers to deliver photosensitizers for photodynamic therapy. Adv. Drug Deliv. Rev. 56, 9 (2004).
213. A. S. Derycke and P. A. de Witte, Liposomes for photodynamic therapy. Adv. Drug. Deliv. Rev. 56, 17 (2004).
214. A. Tripathi, J. S. Melo, and S. F. D'Souza, Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering, edited by A. Tiwari and A. Tiwari, WILEY-Scrivener Publisher, New Jersey (2013), pp. 435-484.
215. M. Hamidi, A. Azadi, and P. Rafiei, Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 60, 1638 (2008).
216. E. Allémann, N. Brasseur, O. Benrezzak, J. Rousseau, S. V. Kudrevich, R. W. Boyle, J. C. Leroux, R. Gurny, and J. E. Van Lier. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J Pharm. Pharmacol. 47, 382 (1995).
217. E. Allémann, J. Rousseau, N. Brasseur, S. V. Kudrevich, K. Lewis, and J. E. Lier, Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer 66, 821 (1996).
218. R. Kopelman, Y. E. L. Koo, M. Philbert, B. A. Moffat, G. R. Reddy, P. McConville, D. E. Hall, T. L. Chenevert, M. S. Bhojani, S. M. Buck, A. Rehemtulla, and B. D. Ross, Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magn. Magn. Mater. 293, 404 (2005).
219. G. R. Reddy, M. S. Bhojani, P. McConville, J. Moody, B. A. Moffat, D. E. Hall, G. Kim, Y. E. Koo, M. J. Woolliscroft, J. V. Sugai, T. D. Johnson, M. A. Philbert, R. Kopelman, A. Rehemtulla, and B. D. Ross, Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer. Res. 12, 6677 (2006).
220. C. W. Lai, Y. H. Wang, C. H. Lai, M. J. Yang, C. Y. Chen, P. T. Chou, C. S. Chan Y. Chi, Y. C. Chen, and J. K. Hsiao, Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: A facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 4, 218 (2008).
221. A. C. Samia, X. Chen, and C. Burda, Semiconductor quantum dots for photodynamic therapy. J. Am. Chem. Soc. 125, 15736 (2003).
222. A. C. Samia, S. Dayal, and C. Burda, Quantum dots-based energy transfer: Perspectives and potential for applications in photodynamic therapy. Photochem. Photobiol. 83, 617 (2006).
223. S. Dayal, Y. Lou, A. C. Samia, J. C. Berlin, M. E. Kenney, and C. Burda, Observation of non-Forster-type energy-transfer behavior in quantum dot-phthalocyanine conjugates. J. Am. Chem. Soc. 128, 13974 (2006).
224. W. Chen and J. Zhang, Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 6, 1159 (2006).
225. E. Frohlich, Cellular targets and mechanisms in the cytotoxic action of non-biodegradable engineered nanoparticles. Curr. Drug. Metab. 14, 976 (2013).
226. K. Baba, H. E. Pudavar, I. Roy, T. Y. Ohulchanskyy, Y. Chen, R. Pandey, and P. N. Prasad, A new method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. Mol. Pharm. 4, 289 (2007).
227. J. F. Coelho, P. C. Ferreira, P. Alves, R. Cordeiro, A. C. Fonseca, J. R. Gois, and M. H. Gil, Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. EPMA J. 1, 164 (2010).
228. Y. Liu, W. Chen, S. Wang, and A. G. Joly, Investigation of water soluble X-ray luminescence nanoparticles for photodynamic activation. Appl. Phys. Lett. 92, 043901 (2008).
229. A. Khdair, B. Gerard, H. Handa, G. Mao, M. P. Shekhar, and J. Panyam, Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Mol. Pharmacol. 5, 795 (2008).
230. Y. N. Konan, M. Berton, R. Gurny, and E. Allemann, Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl) porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 18, 241 (2003).
231. J. R. McCarthy, J. M. Perez, C. Brückner, and R. Weissleder, Polymeric nanoparticle preparation that eradicates tumors. Nano Lett. 5, 2552 (2005).
232. M. Zeisser-Labouebe, F. Delie, R. Gurny, and N. Lange, Benefits of nanoencapsulation for the hypericin-mediated photodetection of ovarian micrometastases. Eur. J. Pharm. Biopharm. 71, 207 (2009).
233. M. Zeisser-Labouebe, N. Lange, R. Gurny, and F. Delie, Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int. J. Pharm. 326, 174 (2006).
234. W. Tang, H. Xu, E. J. Park, M. A. Philbert, and R. Kopelman, Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem. Biophys. Res. Commun. 369, 579 (2008).
235. P. Rai, S. Malidi, X. Zheng, R. Rahmanzadeh, Y. Mir, S. Elrington, A. Khurshid, and T. Hasan, Development and applications of phototriggered theranostic agents. Adv. Drug. Deliv. Rev. 62, 1094 (2010).
236. M. K. Oo, X. Yang, H. Du, and H. Wang, 5-Aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine 3, 777 (2008).
237. N. Sobhani, A. Sazgarnia, O. Rajabi, S. Soudmand, and N. Naghavi, A study on the photobleaching effect of 5-ALA conjugated gold nanoparticles in a CT26 tumor model during photodynamic therapy. Iranian J. Med. Phys. 9, 217 (2012).
238. A. Srivatsan, M. Ethirajan, S. K. Pandey, S. Dubey, X. Zheng. T. H. Liu, M. Shibata, J. Missert, J. Morgan, and R. K. Randey, Conjugation of cRGD peptide to chlorophyll-a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing(PDT) efficacy. Mol. Pharm. 8, 1186 (2011).
239. J. J. Chalmers, Y. Xiong, X. Jin, M. Shao, X. Tong, S. Farag, and M. Zborowski, Quantification of non-specific binding of magnetic micro and nano particles using cell tracking velocimetry: Implication for magnetic cell separation and detection. Biotechnol. Bioeng. 105, 1078 (2010).
240. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji, A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control Release 126, 187 (2008).
241. M. K. Yu, J. H. Park, and S. Y. Jon, Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2, 3 (2012).
242. S. Mura, J. Nicolas, and P. Couvreur, Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991 (2013).
243. A. Prokop and J. M. Davidson, Nanovehicular intracellular delivery systems. J. Pharm. Sci. 97, 3518 (2008).
244. Y. Yu, L. Xu, J. Chen, H. Gao, S. Wang, J. Fang, and S. Xu, Hydrothermal synthesis of GSH-TGA co-capped CdTe quantum dots and their application in labeling colorectal cancer cells. Colloids Surf. B Biointerfaces 95, 247 (2012).
245. P. Magadala and M. Amiji, Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells. AAPS J. 10, 565 (2008).
246. G. Kaul and M. Amiji, Biodistribution and targeting potential of poly(ethylebe glycol)-modified gelatin nanoparticles in subcutaneous murin tumor model. J. Drug Target 12, 589 (2004).
247. W. Gao, K. Xu, L. Ji, and B. Tang, Effect of gold nanoparticles on glutathione depletion-induced hydrogen peroxide generation and apoptosis in HL7702 cells. Toxicol. Lett. 205, 86 (2011).
248. L. J. Cruz, P. J. Tacken, R. Fokkink, and C. G. Figdor, The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells. Biomaterials 32, 6791 (2011).
249. G. Fontana, M. Licciardi, S. Mansueto, D. Schillaci, and G. Giammona, Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22, 2857 (2001).
250. J. Domingo-Espin, V. Petegnief, N. de Vera, O. Conchillo-Sole, P. Saccardo, U. Unzueta, E. Vazquez, J. Cedano, L. Negro, X. Daura, H. Peluffo, A. M. Planas, A. Villaverde, and N. Ferrer-Miralles, RGD-based cell ligands for cell-targeted drug delivery act as potent trophic factors. Nanomedicine 8, 1263 (2012).
251. J. Lee, S. G. Jung, C. S. Park, H. Y. Kim, C. A. Batt, and Y. R. Kim, Tumor-specific hybrid polyhydroxybutyrate nanoparticle: Surface modification of nanoparticle by enzymatically synthesized functional block copolymer. Bioorg. Med. Chem. Lett. 21, 2941 (2011).
252. H. J. Schluesener, Y. Su, A. Ebrahimi, and D. Pouladsaz, Antimicrobial peptides in the brain: Neuropeptides and amyloid. Front. Biosci. 4, 1375 (2012).
253. O. C. Farokhzad, S. Jon, A. Khademhosseini, T. N. Tran, D. A. Lavan, and R. Langer, Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res. 64, 7668 (2004).
254. L. Polo-Corrales, M. Latorre-Esteves, and J. E. Ramirez-Vick, Scaffold Design for Bone Regeneration. J. Nanosci. Nanotechnol. 14, 15 (2014).
255. V. Shabafrooz, M. Mozafari, D. Vashaee, and L.Tayebi, Electrospun nanofibers: From filtration membranes to highly specialized tissue engineering scaffolds. J. Nanosci. Nanotechnol. 14, 522 (2014).
256. V. J. Mkhabela and S. Sinha Ray, Poly(ε-caprolactone) nanocomposite scaffolds for tissue engineering: A brief overview. J. Nanosci. Nanotechnol. 14, 535 (2014).
257. R. Obregón, J. Ramón-Azcón, S. Ahadian, H. Shiku, H. Bae, M. Ramalingam, and T. Matsue, The use of microtechnology and nanotechnology in fabricating vascularized tissues. J. Nanosci. Nanotechnol. 14, 487 (2014).
258. J. Dobson, Remote control of cellular behaviour with magnetic nanoparticles. Nat. Nanotechnol. 3, 139 (2008).
259. I. W. Hamley, Nanotechnology with soft materials. Angew. Chem. Int. Ed. 42, 1692 (2003).
260. T. Tepper, F. Ilievski, C. A. Rose, T. R. Zaman, R. J. Ram, S. Y. Sung, and B. J. H. Stadler, Magneto-optical properties of iron oxide films. J. Appl. Phys. 93, 6948 (2003).
261. C. Yee, G. Kataby, A. Ulman, T. Prozorov, H. White, A. King, M. Rafailovich, J. Sokolov, and A. Edanken, Self-assembled monolayers of alkanesulfonic and -phosphonic acids on amorphous iron oxide nanoparticles. Langmuir 15, 7111 (1999).
262. Y. Sahoo, H. Pizem, T. Fried, D. Golodniysky, L. Burstein, C. N. Sukenik, and G. Markovich, Alkyl phosphonate/phosphate coating on magnetite nanoparticles: A comparison with fatty acids. Langmuir 17, 7907 (2001).
263. A. K. Gupta and M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995 (2005).
264. J. Lin, W. Zhou, A. Kumbhar, J. Fang, E. E. Carpenter, and C. J. O'Connor, Gold-coated iron (Fe@Au) nanoparticles: Synthesis, characterization, and magnetic field-induced self-assembly. J. Solid. State. Chem. 159, 26 (2001).
265. F. Mahtab, Y. Yu, J. W. Y. Lam, J. Liu, B. Zhang, P. Lu, X. Zhang, and B. Z. Tang, Fabrication of silica nanoparticles with both efficient fluorescence and strong magnetization and Exploration of their biological applications. Adv. Funct. Mater. 21, 1733 (2011).
266. A. Ulman, Formation and structure of self-assembled monolayers. Chem. Rev. 96, 1533 (1996).
267. E. Ruiz-Hernandez, A. Baeza, and M. Vallet-Regi, Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano 5, 1259 (2011).
268. S. Santra, R. Tapec, N. Theodoropoulou, J. Dobson, A. Hebard, and W. Tan, Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: The effect of nonionic surfactants. Langmuir 17, 2900 (2001).
269. J. Kim, H. S. Kim, N. Lee, T. Kim, H. Kim, T. Yu, I. C. Song, W. K. Moon, and T. Hyeon, Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed. 47, 8438 (2008).
270. J. W. Bulte, T. Douglas, B. Witwer, S. C. Zhang, E. Strable, B. K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B. M. Moskowitz, I. D. Duncan, and J. A. Frank, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141 (2001).
271. J. M. Veranth, E. G. Kaser, M. M. Veranth, M. Koch, and G. S. Yost, Cytokine responses of human lung cells (BEAS-2B) treated with oxide micron-sized and nanoparticles compared to soil dusts. Part. Fibre Toxicol. 4, 1 (2007).
272. U. O. Hafeli, J. S. Riffle, L. Harris-Shekhawat, A. Carmichael Baranauskas, F. Mark, J. P. Dailey, and D. Bardenstein, Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 6, 1417 (2009).
273. B. Ankamwar, T. C. Lai, J. H. Huang, R. S. Liu, M. Hsiao, C. H. Chen, and Y. K. Hwu, Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnol. 21, 75102 (2010).
274. N. Singh, G. J. S. Jenkins, R. Asadi, and S. H. Doak, Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 1, 5358 (2010).
275. A. Stroh, C. Zimmer, C. Gutzeit, M. Jakstadt, F. Marschinke, T. Jung, H. Pilgrimm, and T. Grune, Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic. Biol. Med. 36, 976 (2004).
276. A. Ito and M. Kamihira, Tissue Engineering Using Magnetite Nanoparticles, Progress in Molecular Biology and translation science, edited by A. Villaverde, Burlington Academic Press, Elseveir (2011), Vol. 104, pp. 355-395.
277. H. Green, O. Kehinde, and J. Thomas, Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl. Acad. Sci. USA 76, 5665 (1979).
278. E. Bell, H. P. Ehrlich, D. J. Buttle, and T. Nakatsuji, Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211, 1052 (1981).
279. A. Ito, M. Hayashida, H. Honda, K. Hata, H. Kagami, M. Ueda, and T. Kobayashi, Tissue engineering using magnetite nanoparticles and magnetic force: Eterotypic layers of cocultured hepatocytes and endothelial cells. Tissue Eng. 10, 833 (2004).
280. A. Ito, T. Takahashi, Y. Kawabe, and M. Kamihira, Human beta defensin-3 engineered keratinocyte sheets constructed by a magnetic force-based tissue engineering technique. J. Biosci. Bioeng. 108, 244 (2009).
281. N. Bock, A. Riminucci, C. Dionigi, A. Russo, A. Tampieri, E. Landi, V. A. Goranov, M. Marcacci, and V. Dediu, A novel route in bone tissue engineering: Magnetic biomimetic scaffolds. Acta Biomater. 6, 786 (2010).
282. Y. Yamamoto, A. Ito, M. Kato, Y. Kawabe, K. Shimizu, H. Fujita, E. Nagamori, and M. Kamihira, Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering technique. J. Biosci. Bioeng. 108, 538 (2009).
283. A. Tampieri, E. Landi, F. Valentini, M. Sandri, T. D'Alessandro, V. Dediu, and M. Marcacci, A conceptually new type of bio-hybrid scaffold for bone regeneration. Nanotechnology 22, 015104 (2011).
284. K. Shimizu, A. Ito, J. K. Lee, T. Yoshida, K. Miwa, H. Ishiguro, Y. Numaguchi, T. Murohara, I. Kodama, and H. Honda, Construction of multi-layered cardiomyocyte sheets using magnetite nanoparticles and magnetic force. Biotechnol. Bioeng. 96, 803 (2007).
285. A. Ito, H. Jitsunobu, Y. Kawabe, and M. Kamihira, Construction of heterotypic cell sheets by magnetic force-based 3-D coculture of HepG2 and NIH3T3 cells. Biotechnol. Bioeng. 104, 371 (2007).